Association between the Amplification Parameters of the α‐Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease

Documenti analoghi

• Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha‐Synuclein Seed Amplification Assay
  di: Sarah M. Brooker, et al.
  Pubblicazione: (2026)
• Comparison of Two α‐Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism
  di: Marcello Rossi, et al.
  Pubblicazione: (2025)
• Rethinking Mitochondrial Parkinson's Disease in the α‐Synuclein Seed Amplification Assays Era
  di: Marco Percetti, et al.
  Pubblicazione: (2026)
• Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
  di: David P. Vaughan, et al.
  Pubblicazione: (2024)
• Detection of α‐Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder
  di: Yuanchu Zheng, et al.
  Pubblicazione: (2024)